Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer

Go back to Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
(NASDAQ: XLO) Delayed: 9.08 -0.15 (1.63%)
Previous Close $9.23    52 Week High
Open $9.21    52 Week Low
Day High $9.21    P/E N/A 
Day Low $9.07    EPS
Volume 3,545